What Do We Need Next?

Faculty(s)

• 

  Steve Elias, MD, FACS, DFAVF DABVLM

  Director, Center for Vein Disease
  Englewood Health Network
  Englewood, NJ, United States

  Disclosure(s): Avail Inc.: Consultant/Advisory Board; BD Bard: Consultant/Advisory Board; Boston Scientific: Consultant/Advisory Board; Cook Inc.: Consultant/Advisory Board; Crossfire Medical: Consultant/Advisory Board; EnVveno: Stock Options; Medtronic Inc.: Consultant/Advisory Board; Philips Inc.: Consultant/Advisory Board; Tactile Medical: Consultant/Advisory Board; Theraclion: Other Research Support; USA Therm: Consultant/Advisory Board; VB Devices: Consultant/Advisory Board; VVT Medical: Stock options
• 

  Ahmed Gaweesh, MSc, MD, dECOP (he/him/his)

  Vascular Surgery Consultant
  Alexandria University
  Alexandria University
  Alexandria, Al Iskandariyah, Egypt

  Disclosure(s): ATCO Pharma: Speaker/Honoraria; Bayer: Speaker/Honoraria; BD: Speaker/Honoraria; Inspire Pharma (Pixaspire): Speaker/Honoraria; Inspire Pharma (Rivarospire): Speaker/Honoraria; Pfizer: Speaker/Honoraria; Sanofi: Speaker/Honoraria
• 

  Jorge Ulloa

  Disclosure information not submitted.
• 

  Cees H.A. Wittens, MD, PhD

  International Chair
  ECoP
  the hague, Zuid-Holland, Netherlands

  Disclosure(s):

  The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.